Filing Details
Lexaria Bioscience Corp. (NASDAQ:LEXX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:LEXX
Lexaria Bioscience Corp. (LEXX) Files Quarterly Report for Q0
Filing Details Lexaria Bioscience Corp. (NASDAQ:LEXX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 13, 2026. The Healthcare company…
Market Context
Lexaria Bioscience Corp.'s stock currently trades at $0.59 with a market capitalization of $22.4M.
The 10-Q provides Lexaria Bioscience Corp.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Lexaria Bioscience Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LEXX Stock Page
Frequently Asked Questions
Where can I read LEXX's SEC filings?
Browse all filings on our LEXX SEC filings page.
What types of SEC filings does Lexaria Bioscience Corp. file?
Public companies like Lexaria Bioscience Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.